ClearPoint Neuro Inc. (CLPT) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Clearpoint Neuro Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.252 The comments made on this call may include statements that are forward-looking within 00:00:03.252 -- 00:00:07.713 the meaning of securities laws. These forward-looking statements may include, without 00:00:07.713 -- 00:00:13.255 limitation, the company's plans, prospects, and strategies, and its beliefs, 00:00:13.255 -- 00:00:19.497 estimates, or projections regarding future revenue and results of operations. 00:00:19.497 -- 00:00:24.358 You are cautioned not to place undue reliance on forward-looking statements which speak 00:00:24.358 -- 00:00:27.319 only as of the date on which they are made. 00:00:27.319 -- 00:00:30.331 Actual results or trends could differ materially. 00:00:30.331 -- 00:00:35.216 The company undertakes no obligation to revise forward-looking statements for the new 00:00:35.216 -- 00:00:39.842 information or future events, except as required by law. 00:00:39.842 -- 00:00:44.246 For more information about the company's risks and uncertainties, please refer to the 00:00:44.246 -- 00:00:49.392 company's filings with the SEC, including the company's recent filings on Form 8K, 00:00:49.392 -- 00:00:54.530 Form 10K, and Form 10Q. All the company's filings may be obtained 00:00:54.530 -- 00:00:59.952 from the SEC or the company's website at www.clearpointneuro.com. 00:01:01.674 -- 00:01:06.117 And now I'll turn the call over to Joe Burnett, Chief Executive Officer. 00:01:06.117 -- 00:01:08.837 Thank you. You may begin. 00:01:10.779 -- 00:01:15.902 Thank you. And as always, thank you to all the investors, analysts, and biopharma partners 00:01:15.902 -- 00:01:20.941 listening to today's call. We remain both committed to and focused on developing a 00:01:20.941 -- 00:01:25.647 complete neuro ecosystem capable of delive...